Tumour Necrosis Factor Inhibitors and Infection: What Is there to Know for Infectious Diseases Physicians?
At this year's meeting of Digestive Disease Week in Los Angeles, California, it was noted that antitumour necrosis factor (anti-TNF) inhibitors showed further evidence of efficacy in Crohn's disease (1). TNF antagonists have been used increasingly in the treatment of a number of other infl...
Saved in:
| Main Authors: | BL Johnston, JM Conly |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2006-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2006/385789 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Natural Disasters, Corpses and the Risk of Infectious Diseases
by: JM Conly, et al.
Published: (2005-01-01) -
The Changing Face of Canadian Immigration: Implications for Infectious Diseases
by: BL Johnston, et al.
Published: (2008-01-01) -
Why the West in West Nile virus infections?
by: JM Conly, et al.
Published: (2007-01-01) -
Lyme Disease: Is It or Is It Not?
by: BL Johnston, et al.
Published: (2005-01-01) -
Alemtuzumab and Natalizumab: The Monoclonal Antibody Story Continues
by: BL Johnston, et al.
Published: (2006-01-01)